Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT05434598

Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS

Led by Washington University School of Medicine · Updated on 2025-12-11

60

Participants Needed

1

Research Sites

265 weeks

Total Duration

On this page

Sponsors

W

Washington University School of Medicine

Lead Sponsor

A

American Society of Hematology

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a single institution, prospective study of the whole genome sequencing assay, ChromoSeq. Using prospectively collected patient data, coupled with physician surveys, the investigators seek to determine the feasibility of implementing ChromoSeq in addition to standard genomic testing, for patients with the diagnosis of myelodysplastic syndrome (MDS).

CONDITIONS

Official Title

Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of myelodysplastic syndrome (MDS) or clinical suspicion of new MDS diagnosis with planned routine diagnostic testing
  • Seen in the outpatient setting
  • Not previously treated with disease-modifying therapies such as lenalidomide or hypomethylating agents
  • May have received transfusional support, erythropoietin-stimulating agents, growth factor support, or luspatercept
  • At least 18 years old
  • Able to understand and willing to sign an IRB-approved written informed consent form
Not Eligible

You will not qualify if you...

  • Younger than 18 years
  • Does not treat patients at Washington University School of Medicine

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110

Actively Recruiting

Loading map...

Research Team

M

Meagan A Jacoby, M.D., Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS | DecenTrialz